C-reactive Protein Analyzer Market - Global Forecast 2025-2030

The C-reactive protein analyzer market is evolving rapidly due to technological innovation, increasing precision-diagnostic demand, and the ongoing shift toward patient-centric care frameworks.

Market Snapshot: C-reactive Protein Analyzer Market Growth and Outlook

The C-reactive protein analyzer market grew from USD 2.06 billion in 2024 to USD 2.17 billion in 2025. It is expected to continue growing at a CAGR of 5.52%, reaching USD 2.85 billion by 2030.

Scope & Segmentation

• Type: Laboratory automation systems, including chemistry analyzers and immunoassay analyzers, as well as point-of-care devices.
• Detection Technology: Enzyme-linked immunosorbent assay, fluorescence polarization, immunonephelometry, immunoturbidimetric approaches.
• Sample Types: Blood, plasma, and serum for diverse clinical applications.
• Portability: Fixed laboratory modules and portable devices for field or bedside use.
• Application Areas: Autoimmune disease management, cardiovascular risk assessment, gastrointestinal disease tracking, infection monitoring (bacterial and viral), and inflammation monitoring.
• End Users: Diagnostic laboratories, hospitals and clinics, and research institutes.
• Sales Channels: Offline sales through direct manufacturers and distributors, as well as online channels including brand websites and e-commerce platforms.
• Regional Coverage: Americas (United States, Canada, Mexico, Brazil, and others), Europe (United Kingdom, Germany, France, etc.), Middle East and Africa (UAE, South Africa, Nigeria), Asia-Pacific (China, India, Japan, Australia, Singapore, among others).
• Leading Companies Profiled: Zoetis Inc. (Abaxis), Abbott Laboratories, Roche, Danaher Corporation, Siemens Healthineers AG, Mindray, HORIBA, biosurfit, Nova Biomedical, SD Biosensor, and others.

Key Takeaways for Decision-Makers

• Technological advances have integrated high-throughput laboratory automation with agile point-of-care analyzers, broadening diagnostic flexibility and supporting both large-scale and site-specific care.
• Digital health integration and laboratory information management systems are streamlining data access, improving analytics, and bolstering the value of C-reactive protein analyzer use in population health initiatives.
• Multiple detection technologies enable tailored performance for sensitivity, speed, and reproducibility, with each platform suiting distinct clinical settings and operational needs.
• Segmented sample collection approaches optimize workflows; whole blood, plasma, and serum each serve unique roles in acute, standard, and research diagnostics.
• Strategic supplier agreements, dual sourcing, and tariff-monitoring strategies are helping stakeholders mitigate procurement disruption and maintain operational resilience amid shifting trade environments.

Tariff Impact and Supply Chain Strategies

Recent U.S. tariff measures have increased procurement costs for imported instruments and consumables, prompting stakeholders to localize manufacturing and diversify suppliers. Organizations have expanded dual sourcing, pursued longer-term supply contracts, and sought tariff exclusions where possible. This environment has accelerated the adoption of volume-based pricing models and encouraged close collaboration between equipment producers and reagent manufacturers, supporting cost control and continuity of supply.

Research Methodology & Data Sources

The analysis uses a structured methodology combining desk research, published literature, and regulatory documentation with expert interviews from leading laboratories, manufacturers, and healthcare networks. Quantitative and qualitative data were triangulated to enhance reliability. Open collaboration with industry stakeholders ensured segmentation frameworks and mapping reflect real-world priorities.

Why This Report Matters

• Delivers actionable insights to help stakeholders optimize product portfolios, identify high-value market segments, and improve procurement efficiencies.
• Enables strategy leaders to anticipate regulatory developments, emerging technology trends, and regional demand shifts affecting the C-reactive protein analyzer market.

Conclusion

The C-reactive protein analyzer market is positioned for continued growth through detection technology advancements, digital integration, and robust supply chain strategies. Decision-makers can leverage the insights from this report to adapt their operations and capture emerging opportunities in global diagnostics.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.